RT Journal Article
SR Electronic
T1 Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.06.20092957
DO 10.1101/2020.05.06.20092957
A1 Anthony P Khawaja
A1 Alasdair N Warwick
A1 Pirro G Hysi
A1 Alan Kastner
A1 Andrew Dick
A1 Peng T Khaw
A1 Adnan Tufail
A1 Paul J Foster
A1 Kay-Tee Khaw
YR 2020
UL http://medrxiv.org/content/early/2020/05/11/2020.05.06.20092957.abstract
AB OBJECTIVES To identify the sociodemographic, lifestyle, comorbidity and antihypertensive medication associations with the development of hospitalisation with covid-19 in an English population.DESIGN Prospective cohort studySETTING The population-based UK Biobank study was linked to English covid-19 test results.PARTICIPANTS Individuals resident in England and alive in 2020.MAIN OUTCOME MEASURES Cases (n=605) were defined by a positive covid-19 test result conducted between 16th March and 16th April 2020, during a restricted testing policy for hospitalised individuals with severe disease.RESULTS A total of 406,793 participants were included. Mean age on 1st January 2020 was 68 years (range 48 to 85 years). 55% were women. In multivariable models, major independent risk factors for hospitalisation with covid-19 were male sex (odds ratio 1.52; 95% confidence interval 1.28 to 1.81; P<0.001), South Asian ethnicity (2.02; 1.28 to 3.17; P=0.002) or black ethnicity (3.09; 2.18 to 4.38; P<0.001) compared to white ethnicity, greater residential deprivation (1.92 for most deprived quartile compared to least deprived quartile; 1.50 to 2.47; P<0.001), higher BMI (2.04 for BMI >35 compared to <25 Kg/m2; 1.50 to 2.77; P<0.001), former smoking (1.39 compared to never smoked; 1.16 to 1.66; P<0.001), and comorbidities hypertension (1.28; 1.06 to 1.53; P=0.009) and chronic obstructive pulmonary disease (1.81; 1.34 to 2.44; P<0.001). Increased risk was observed with increasing number of antihypertensive medications used rather than any individual class.CONCLUSION Understanding why these factors confer increased risk of severe covid-19 in the population may help elucidate the underlying mechanisms as well as inform strategy and policy to prevent this disease and its consequences. We found no evidence of increased risk with specific classes of antihypertensive medication.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUK Biobank was established by the Wellcome Trust, Medical Research Council, Department of Health, Scottish government, and Northwest Regional Development Agency. It has also had funding from the Welsh assembly government and the British Heart Foundation. APK was supported by a Moorfields Eye Charity Career Development Fellowship. ANW was a Wellcome Trust clinical research fellow. PTK and PJF were supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology. PJF received additional support from The Richard Desmond Charitable Trust.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearchers wishing to access UK Biobank data can register and apply at https://www.ukbiobank.ac.uk/